Reaction Biology Corporation (United States)

Institution (Company)

Homepage ROR

Also Known As

Reaction Biology Corporation (United States) · Acronym: RBC

318

Publications

27K

Citations

Authors

284

Concepts

About

Reaction Biology Corporation (United States) is a company institution in Malvern, United States known for medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	19	1.7K
2	Business	5	5	992
3	Health Sciences	3	7	98
4	Management	3	3	961
5	Education	2	4	678

Reaction Biology Corporation (United States)

318

Publications

27K

Citations

Page 1

	Year	Citations
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity Theonie Anastassiadis, Sean Deacon, Karthik Devarajan, Nature Biotechnology Drug TargetSignal TransductionSignaling PathwayBiochemistryMedicine	2011	909
Actualizing Organizational Memory with Information Systems Eric W. Stein, Vladimir Zwass Information Systems Research Knowledge Management StrategyOmis ImplementationCognitive ScienceOrganizational SystemOrganizational Communication	1995	837
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody David Knight, Han Trinh, Junming Le, Molecular Immunology Autoimmune DiseaseAllergyImmunologyImmunodominanceAntibody Screening	1993	710
Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions Bernard J. Scallon Cytokine Signal TransductionImmune Effector FunctionsImmunologyTumor ImmunityImmunologic Mechanism	1995	680
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists Bernie Scallon, Ann Cai, Nancy Solowski, Journal of Pharmacology and Experimental Therapeutics	2002	667
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets C L Wagner, MA Mascelli, DS Neblock, Blood	1996	435
Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis P. Charles, Michael J. Elliott, Diana Davis, The Journal of Immunology ImmunologyImmune RegulationAcute-phase ProteinsAnti-tnf-α TherapyInnate Immunity	1999	433
Stable cell membrane labelling Paul K. Horan, Sue E. Slezak Nature Membrane TransportStable Cell MembraneMembrane BiologyCytoskeletonCellular Structure	1989	321
Tumor necrosis factor‐alpha (<scp>TNF‐α</scp>) is a therapeutic target for impaired cutaneous wound healing Gillian S. Ashcroft, Moon‐Jin Jeong, Jason Ashworth, Wound Repair and Regeneration	2011	269
Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors Ramachandran Vijayan, Peng He, Vivek Modi, Journal of Medicinal Chemistry Drug TargetKinase InhibitorsMolecular BiologyReceptor Tyrosine KinaseDfg-out Kinase Motif	2014	230

Page 1